Catalyst Event

Samsung Biologics Co Ltd (207940) · Other

From Akros K-Manufacturing 50 Index (AKMNF50)

3/20/2026, 12:00:00 AM

OtherSentiment: Neutral

The 15th Annual General Meeting of Shareholders was held on March 20, 2026, to approve FY2025 financial statements and re-appoint CEO John Rim; Medium importance estimated due to governance stability.

Korean Translation

2026년 3월 20일 제15기 정기주주총회를 개최하여 2025년 재무제표 승인 및 존 림 대표이사 재선임 안건을 처리함. 지배구조 안정화에 따른 Medium 중요도 예상됨.

Related Recent Events

View Full Timeline